VRS
CRSP icon

Virginia Retirement Systems’s CRISPR Therapeutics CRSP Stock Holding History

Virginia Retirement Systems’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$970K Sell
17,780
-900
-5% -$47.4K 0.01% 772
2026
Q1 		$889K Sell
18,680
-1,200
-6% -$63.3K 0.01% 625
2025
Q4 		$1.04M Buy
19,880
+5,550
+39% +$332K 0.01% 568
2025
Q3 		$929K Sell
14,330
-7,900
-36% -$454K 0.01% 614
2025
Q2 		$1.08M Sell
22,230
-2,700
-11% -$104K 0.01% 553
2025
Q1 		$848K Buy
+24,930
New +$1.06M 0.01% 599
2023
Q3 		$971K Buy
21,400
+9,600
+81% +$496K 0.01% 516
2023
Q2 		$662K Buy
11,800
+4,400
+59% +$250K 0.01% 652
2023
Q1 		$335K Buy
+7,400
New +$359K ﹤0.01% 849
2022
Q4 		– Sell
-13,600
Closed -$889K – 1147
2022
Q3 		$889K Buy
+13,600
New +$986K 0.01% 611
2022
Q1 		$1.14M Buy
18,200
+1,100
+6% +$69.1K 0.01% 590
2021
Q4 		$1.3M Buy
17,100
+1,800
+12% +$157K 0.01% 562
2021
Q3 		$1.71M Buy
15,300
+8,900
+139% +$1.12M 0.02% 467
2021
Q2 		$1.04M Sell
6,400
-600
-9% -$73K 0.01% 638
2021
Q1 		$853K Buy
7,000
+2,500
+56% +$377K 0.01% 710
2020
Q4 		$689K Sell
4,500
-10,600
-70% -$1.25M 0.01% 738
2020
Q3 		$1.26M Buy
15,100
+800
+6% +$71K 0.01% 481
2020
Q2 		$1.05M Buy
14,300
+400
+3% +$23.4K 0.01% 540
2020
Q1 		$589K Buy
+13,900
New +$718K 0.01% 735

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Virginia Retirement Systems's CRSP Position: Q2 2026 in Review

Virginia Retirement Systems reduced its CRISPR Therapeutics (CRSP) stake by 4.8% in Q2 2026, selling an estimated $47.4K and leaving 17,780 shares worth $970K. The position accounts for 0.01% of the portfolio, ranked #772.

Virginia Retirement Systems first reported a position in CRSP in Q1 2020 and has held it in 19 quarters since. The position peaked at $1.71M in Q3 2021. 523 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Virginia Retirement Systems held 17,780 shares of CRISPR Therapeutics worth $970K as of Q2 2026.
  • Virginia Retirement Systems sold 900 CRISPR Therapeutics shares in Q2 2026, an estimated $47.4K.
  • CRISPR Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #772 holding.
  • Virginia Retirement Systems first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 19 quarters since.
  • Virginia Retirement Systems's CRISPR Therapeutics position peaked at $1.71M in Q3 2021.
  • 523 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.